JPS5283545A - Tri-and tetrapeptides and their derivatives - Google Patents
Tri-and tetrapeptides and their derivativesInfo
- Publication number
- JPS5283545A JPS5283545A JP21776A JP21776A JPS5283545A JP S5283545 A JPS5283545 A JP S5283545A JP 21776 A JP21776 A JP 21776A JP 21776 A JP21776 A JP 21776A JP S5283545 A JPS5283545 A JP S5283545A
- Authority
- JP
- Japan
- Prior art keywords
- tetrapeptides
- tri
- derivatives
- pyrrolidine
- proline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 3
- -1 1-adamantanecarbonyl Chemical group 0.000 abstract 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 abstract 2
- 239000004471 Glycine Substances 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-Leucine Natural products CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 abstract 1
- 235000019393 L-cystine Nutrition 0.000 abstract 1
- 239000004158 L-cystine Substances 0.000 abstract 1
- 239000004395 L-leucine Substances 0.000 abstract 1
- 235000019454 L-leucine Nutrition 0.000 abstract 1
- 125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- 229930195722 L-methionine Natural products 0.000 abstract 1
- 229930182821 L-proline Natural products 0.000 abstract 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 abstract 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
- 108010077895 Sarcosine Proteins 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 229960003067 cystine Drugs 0.000 abstract 1
- 229960002989 glutamic acid Drugs 0.000 abstract 1
- 229960003136 leucine Drugs 0.000 abstract 1
- 229960004452 methionine Drugs 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229960002429 proline Drugs 0.000 abstract 1
- 229940043230 sarcosine Drugs 0.000 abstract 1
- 229960004799 tryptophan Drugs 0.000 abstract 1
- 229960004441 tyrosine Drugs 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21776A JPS5283545A (en) | 1976-01-01 | 1976-01-01 | Tri-and tetrapeptides and their derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21776A JPS5283545A (en) | 1976-01-01 | 1976-01-01 | Tri-and tetrapeptides and their derivatives |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56174348A Division JPS5830299B2 (ja) | 1981-10-30 | 1981-10-30 | トリペプチドおよびその誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5283545A true JPS5283545A (en) | 1977-07-12 |
| JPS5720298B2 JPS5720298B2 (enrdf_load_html_response) | 1982-04-27 |
Family
ID=11467783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21776A Granted JPS5283545A (en) | 1976-01-01 | 1976-01-01 | Tri-and tetrapeptides and their derivatives |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5283545A (enrdf_load_html_response) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5132119A (en) * | 1989-07-31 | 1992-07-21 | Massachusetts Institute Of Technology | Treatment of hypertrophic wound healing disorders with calcium channel blockers |
| US5569678A (en) * | 1989-07-31 | 1996-10-29 | Massachusetts Institute Of Technology | Control of wound scar production |
| WO2003008380A1 (fr) * | 2001-07-18 | 2003-01-30 | Ajinomoto Co., Inc. | Derives d'acide carboxylique |
-
1976
- 1976-01-01 JP JP21776A patent/JPS5283545A/ja active Granted
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5132119A (en) * | 1989-07-31 | 1992-07-21 | Massachusetts Institute Of Technology | Treatment of hypertrophic wound healing disorders with calcium channel blockers |
| US5569678A (en) * | 1989-07-31 | 1996-10-29 | Massachusetts Institute Of Technology | Control of wound scar production |
| US5902609A (en) * | 1989-07-31 | 1999-05-11 | Massachusetts Institute Of Technology | Composition for the control of wound scar production |
| WO2003008380A1 (fr) * | 2001-07-18 | 2003-01-30 | Ajinomoto Co., Inc. | Derives d'acide carboxylique |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5720298B2 (enrdf_load_html_response) | 1982-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE45086L (en) | Amino acids. | |
| GB2286502B (en) | Chroma keyer with correction for background defects | |
| FI844230L (fi) | Enzyminhibition. | |
| AU564255B2 (en) | Vasotocin derivatives | |
| NZ336793A (en) | Method for stabilizing peptides by adding an organic acid and then lyophilizing the peptide mixture | |
| JPS5283545A (en) | Tri-and tetrapeptides and their derivatives | |
| DE3569541D1 (en) | Pharmacologically active peptides | |
| GB1533077A (en) | 4-substituted enkephalin derivatives | |
| ATE30919T1 (de) | Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel. | |
| DE3268716D1 (en) | Peptides and process for their preparation | |
| DE3665462D1 (en) | Pharmacologically active peptides | |
| EP0248231A3 (en) | Pharmacologically active peptides | |
| JPS5225768A (en) | Preparation of novel pentapeptides | |
| GB1513472A (en) | Polypeptides with acth-like activity | |
| AU4285296A (en) | Bradykinin antagonist peptides containing indane-sustituted amino acids | |
| JPS53132539A (en) | Protected amino acid or peptide having said protected amino acid residue | |
| JPS57145846A (en) | Preparation of tripeptide and its derivative | |
| JPS572213A (en) | Cosmetic | |
| JPS56115708A (en) | Cosmetic | |
| AU555187B2 (en) | Peptide | |
| GB2011909A (en) | Synthetic Analogue of Bradykinin | |
| JPS543072A (en) | Peptide derivatives | |
| GB1532148A (en) | 1-substituted enkepholin derivatives | |
| JPS52139059A (en) | Vinyl process for preparation of n- acyltetra peptides | |
| JPS5419967A (en) | Preparation of phroglutamineglycilamino acid |